BIOMERICA INC

BMRANasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$4.5M

▼ 16.2% YoY

Net Income

-$3.8M

▲ 24.1% YoY

EPS

$-1.30

▲ 39.8% YoY

Cash

$1.3M

▼ 45.5% YoY

FY 2026 · As of 2026-05-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.